Zugriffe | |
---|---|
Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study | 137 |
November 2023 | Dezember 2023 | Januar 2024 | Februar 2024 | März 2024 | April 2024 | Mai 2024 | |
---|---|---|---|---|---|---|---|
Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study | 2 | 1 | 2 | 1 | 4 | 8 | 0 |
Zugriffe | |
---|---|
2021_Correll_etal.pdf | 27 |